Physician profile
Olivia Goad
NPI 1861888455
$2,409.16
in general payments reported to CMS, 2019-2025
19 companies · $465 in 2025
The $465 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.77 · 2022: $379 · 2023: $815 · 2024: $738 · 2025: $465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,018.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,017.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $519.27 | 2022-2025 | Farxiga, Brilinta, Wainua |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $466.02 | 2022-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $292.74 | 2023-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $225.01 | 2022-2025 | |
| Amgen INC. | $197.03 | 2022-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $176.93 | 2022-2025 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $77.46 | 2025 | |
| Alnylam Pharmaceuticals INC. | $68.75 | 2022-2023 | Onpattro |
| Philips North America LLC | $60.46 | 2022-2023 | |
| Kiniksa Pharmaceuticals International, Plc | $55.85 | 2024 | Arcalyst |
| Janssen Pharmaceuticals, INC | $43.55 | 2022 | |
| Kestra Medical Technology Services, INC. | $43.41 | 2023 | Assure Wcd |
| Boston Scientific Corporation | $43.20 | 2024 | Watchman Access System |
| Baxter Healthcare | $42.11 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Amarin Pharma, INC. | $27.29 | 2021-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $24.61 | 2025 | |
| Kiniksa Pharmaceuticals, LTD. | $16.82 | 2023 | Arcalyst |
| Heartflow, INC. | $15.72 | 2025 | |
| Esperion Therapeutics, INC. | $12.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olivia Goad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.